4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000021
President & CEO gave up 4,319 shares (to pay taxes)
- President & CEO acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hirsch Andrew · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-30 | Exercise or conversion : show line 1 in the form | +12,500 | 31,325 | D | ||
| 2023-01-30 | Shares withheld for taxes : show line 2 in the form | −4,319 | $7.78 | $33,602 | 27,006 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-30 | Exercise or conversion : show line 3 in the form Performance Restricted Stock Units | −12,500 | 62,500 | D |
Loading xslF345X03/wf-form4_167528577737212.xml…